Only 37.5% of participants showed temporary skin-lightening with IV glutathione in a key trial, while 32% experienced adverse events according to the clinical review cited later in this article. That single contrast reframes the entire discussion for Swiss clinics. L-glutathione injection is being sold in the market as a fast aesthetic solution, but the commercial